Showing 1-10 of about 141 articles.
BriaCell Therapeutics Corp
Clinical and pathological data from clinical trial of the Bria-IMT™ regimen alone or in combination with immune checkpoint inhibitors in advanced breast cancer will be presented at the Keystone...
BriaCell Therapeutics Corp
Disease control and survival data is presented from the clinical trials of Bria-IMT™ alone or in combination with immune checkpoint inhibitors in advanced breast cancer: Maximum tumor reduction and...
BriaCell Therapeutics Corp
BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 01, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage...
BriaCell Therapeutics Corp
BERKELEY, Calif., and VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage...
BriaCell Therapeutics Corp
BriaCell and National Cancer Institute to collaborate on Bria-OTS™, BriaCell’s off-the-shelf personalized immunotherapy, as a treatment for cancer. BERKELEY, Calif., and VANCOUVER, British Columbia,...
BriaCell Therapeutics Corp
Overall Survival of 13.3 months in patients, including 14 months in patients with Grade I/II tumors, suggesting clinical benefit;Comparison: 7.2-9.8 months in similar patients with metastatic breast...
BriaCell Therapeutics Corp
BERKELEY, Calif., and VANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage...
BriaCell Therapeutics Corp
BERKELEY, Calif., and VANCOUVER, British Columbia, Oct. 01, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) is a clinical-stage...
BriaCell Therapeutics Corp
BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 15, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage...
BriaCell Therapeutics Corp
BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 04, 2020 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage...
Showing 1-10 of about 141 articles.
